Although we have demonstrated the roles of NCX1-mediated Ca2+ signaling in esophageal cancer [18], pancreatic cancer [36] and hepatocellular carcinoma [19], the pathological roles of NCX1 in the stomach, especially in GC development remain totally unexplored. This evidence concerns the gene SLC8A1 and hepatocellular carcinoma.